Lutz Deitinghoff, PhD, is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as General Manager at Catalent Pharma Solutions since October 2019, with full P&L responsibility and as Site Head. Prior experience includes roles at GSK Vaccines as Innovation Lead Quality and Head QC, focusing on microbiology and sterility assurance, and operational leadership positions at Novartis Vaccines in viral operations. Lutz's career began in neuroscience research as a Junior Scientist at Migragen AG and postdoctoral associate at Abbott. Lutz holds a Ph.D. in Biology and a Diplom in Biochemistry from the University of Tübingen.
Links